Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07492160
Eligibility Criteria:
Inclusion Criteria:
* Pregnant people aged 18 years or older
* Gestational age between 12 and 18 weeks
* Undergoing treatment for spontaneous or induced abortion at Maimonides Medical Center
* Able to provide informed consent
* Willing and able to complete study surveys
Exclusion Criteria:
* Prior mastectomy
* Currently breastfeeding
* Current use of a dopamine agonist or dopamine antagonist medication
* Known contraindication to Cabergoline according to the medication prescribing information
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07492160
Study Brief:
Protocol Section:
NCT07492160